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While necroptosis has for long been viewed as an accidental mode of cell death triggered by physical or chemical damage, it has
become clear over the last years that necroptosis can also represent a programmed form of cell death in mammalian cells. Key
discoveries in the field of cell death research, including the identification of critical components of the necroptotic machinery,
led to a revised concept of cell death signaling programs. Several regulatory check and balances are in place in order to ensure
that necroptosis is tightly controlled according to environmental cues and cellular needs. This network of regulatory mechanisms
includes metabolic pathways, especially those linked to mitochondrial signaling events. A better understanding of these signal
transduction mechanisms will likely contribute to open new avenues to exploit our knowledge on the regulation of necroptosis
signaling for therapeutic application in the treatment of human diseases.
1. Introduction
There are several forms of cell death in mammalian cells,
among them apoptosis and necrosis as the two best char-
acterized and most intensively studied modes of cell death
[1]. Apoptosis is characterized by a series of programmed
events, including membrane blebbing, caspase activation,
and internucleosomal DNA fragmentation [1]. In contrast
to apoptosis, necrosis represents a form of cell death that
typically lacks the activation of caspases, while it involves
swelling of mitochondria, irreversible damage to cellular
membranes, eventually leading to spilling of the intracellular
content into the surrounding environment [1]. In addition, a
regulated form of necrosis, that is, necroptosis, has recently
been identified that proceeds in a programmed and con-
trolled manner [2]. Necroptosis refers to RIP1- and/or RIP3-
dependent regulated necrosis [1]. A better understanding of
the molecular mechanisms that regulate necroptosis signal
transduction may open new perspectives for targeted modu-
lation and therapeutic exploitation of necroptosis signaling.
This paper will focus on the crosstalk between necrop-
tosis and metabolic signaling events, in particular redox
signaling.
2. Necroptosis Signaling
Therearevariousstimulithatcanengagenecroptosis,includ-
ing ligands of the death receptor family such as TNF𝗼,
chemicalorphysicaldamage,orhypoxicconditions[2].Since
necroptosis represents a programmed form of cell death,
there are clearly delineated signal transduction cascades that
eventually lead to the demise of the cell.
For example, in TNF𝗼-triggered necroptosis, binding of
thedeathreceptorligandTNF𝗼tocognateplasmamembrane
receptors on the cell surface, that is, TNF receptor 1 (TNFR1)
as the main receptor for TNF𝗼, engages an intracellular
signaling machinery [3] .Th i si n v o l v e st h er e c r u i t m e n to f
adaptor molecules such as TRADD signaling molecules such
asRIP1,cIAP1,cIAP2,TRAF2,andTRAF5tothecytoplasmic
part of TNFR1. The recruitment of the signaling molecules
leads to the formation of the so-called complex I, a multi-
meric protein complex that leads to the polyubiquitination
of RIP1 by cIAP proteins. Following its polyubiquitination,
RIP1 can serve as docking site for TAK1, TAB2 and TAB3
which results in the activation of the transcription factor
NF-𝜅B. Upon binding of TNF𝗼, TNFR1 is internalized
in order to terminate signal transduction via the ligated2 International Journal of Cell Biology
membrane-bound receptor which subsequently leads to a
change in the molecular composition of the interacting
signalingproteins.Thisenablestheformationoftheso-called
TNFR1 complex II which contains core components such
as FADD, RIP1, and caspase-8 and serves as a platform for
caspase-8 activation and initiation of apoptosis. However,
if caspase-8 is insufficiently activated in this complex, an
alternative complex can be formed, that is, the so-called
necrosome complex [2]. This necrosome complex contains
FADD, RIP, and in addition also RIP3 and is critically
required for the initiation of necroptotic cell death. Since
RIP1 can be a part of cell death and survival signaling
complexes, posttranslational modifications of RIP1 ensure
that fine tuning of RIP1 functions in apoptosis versus
necroptosis versus NF-𝜅B signaling is achieved. Accord-
ingly, the ubiquitination of RIP1 favors the formation of
the cell death-initiating platforms, whereas ubiquitinated
RIP is a component of the NF-𝜅B-signaling cascade [2].
Upon the formation of the necrosome complex, RIP1 and
RIP3 become phosphorylated and activated which in turn
engages downstream signaling events that eventually lead to
necroptotic cell death [4]. Of note, these signaling networks
also involve several crosstalks with cellular metabolic path-
ways.
3. RegulationofNecroptosisbyRedoxSignaling
Theregulatorymechanismsthatareinvolvedinthecontrolof
the initiation and propagation of necroptosis are still largely
unknown. There is accumulating evidence that redox pro-
cessesplayanimportantroleintheregulationofnecroptosis.
For example, the production of ROS is rapidly increased dur-
ing the early stages of necroptosis [5, 6] indicating that ROS
generationmaybeinvolvedinmediatingnecroptosis.Indeed,
it has been shown that the inhibition of the production of
reactive oxygen species (ROS) also reduces the induction of
necroptosis [5, 7].
What are the generator systems for ROS production
during necroptosis? There are several potential intracellular
sites that can contribute to ROS production in the course
of necroptosis. In principle, they can be divided into mito-
chondrialgenerator systems andextramitochondrialsites for
ROS production. Within mitochondria, complexes I and III
of the respiratory chain are considered as main sites for ROS
production during programmed cell death [8]. In addition,
the mitochondrial adenine-nucleotide translocates (ANT)
c a nc o n t r i b u t et oR O Sp r o d u c t i o ni nt h ec o u r s eo fc e l ld e a t h .
ANT is localized at the inner mitochondrial membrane and
responsible for the exchange of ADP against ATP [9]. The
inhibition of ANT leads to a decrease of ADP levels with
concomitant increase in ATP in the mitochondrial matrix,
w h i c hi nt u r nr e d u c e st h ea c t i v i t yo ft h eA T Ps y n t h a s ea n d
hyperpolarization of the mitochondrial membrane potential,
thereby favoring the production of ROS [10]. Since RIP1
has been described to negatively regulate ANT activity, it
is tempting to speculate that elevated RIP1 activity during
necroptosis may inactivate ANT, thereby favoring the pro-
duction of ROS species.
As far as extramitochondrial sources of ROS are con-
cerned, NOX NADPH oxidases represent the main sources
of ROS production in the extramitochondrial compartment
[11]. It is interesting to note that the prototypic necroptosis
stimulus TNF𝗼 has recently been reported to increase the
activity of NOX1 complex via a mechanism involving RIP1
[12] .T N F R 1c o m p l e xIh a sa l s ob e e nr e p o r t e dt os e r v ea s
platform, which enables the docking of the NADPH oxidase
NOX1 at the plasma membrane, thereby promoting the
generation of ROS [12] .Th i si n v o l v e st h eT N F 𝗼-stimulated
association of NADPH oxidase organizer 1 (NOXO1) subunit
with RIP1, TRADD and riboflavin kinase, which in turn
results in ROS production via NOX1 [12].
4. ROS Species as Executioners of Necroptosis
A l r e a d yt w e n t yy e a r sa g ot h ee x e c u t i o no fn e c r o t i cc e l l
death has been associated with ROS species as critical
mediators of cell death. It was reported that complex I-
mediated production of ROS species is required for necrotic
cell death in response to TNF𝗼 stimulation [8]. In addition,
ROSproductionwithinthemitochondriahasbeenassociated
with structural changes and damage to organelles such as
mitochondria and the endoplasmic reticulum [8, 13]. In
addition to mitochondrial ROS, the generation of ROS from
extramitochondrial sources, for example, via the plasma
membrane-associated NADPH oxidase NOX1, has been
shown to mediate necrotic cell death upon stimulation with
TNF𝗼 [12]. ROS generation by NOX1 might not only result
in lipid peroxidation and membrane damage but may also
engage a feed-forward amplification loop to trigger further
ROS production via the mitochondrial respiratory chain.
Another amplification loop might involve the lysosomal
compartment where hydrogen peroxide can interact with
ferrous ions to produce hydroxyl radical (Fenton reaction),
a highly reactive ROS species [14]. Such amplification loops
can lead to the overproduction of ROS, for example, at the
mitochondrial respiratory chain. This bears the danger of a
lethal vicious cycle eventually resulting in the generation of
reactive nitrogen species (RNS). RNS species can function
as oxidants to produce protein or lipid oxidation, thereby
alteringproteinfunctionandcausingmembranedamage[15].
M o r e o v e r ,R O Sg e n e r a t i o nh a sa l s ob e e nl i n k e dt om i t o -
chondrial bioenergetics. To this end, advanced glycation
end products (AGE) which are generated as the result of
several chemical reactions in response to elevated levels of
extracellular glucose have been reported to bind to receptors
on the cell surface and to promote ROS production [16].
5. Bioenergetic Regulation of Necroptosis
Apoptosis and necrosis not only represent morphologically
two distinct forms of cell death but also from the aspect of
bioenergetics demands. The initial characterization of apop-
totic and necrotic cell death has revealed that intracellular
adenosine triphosphate (ATP) content represents a central
regulator in the decision on the mode of cell death, that
is, apoptosis and necrosis. Accordingly, human T-cells haveInternational Journal of Cell Biology 3
been reported to switch from apoptosis in response to CD95
stimulationortreatmentwithstaurosporinetowardsnecrosis
upon depletion of ATP [17]. In this model, the generation
of ATP by either the mitochondrial respiratory chain or by
glycolysis was shown to be necessary to provide the energetic
supply to execute apoptosis via DNA fragmentation [17].
The addition of extramitochondrial ATP, for example, by
repletion of glucose, resulted in restored ability of T cells
to undergo apoptotic cell death [17]. Subsequently, different
steps in the apoptotic signaling cascade were shown to
depend on sufficient supply of bioenergetics substrates and
ATP consumption, for example, activity of the translational
machinery,proteindegradationviatheubiquitinproteasome
system, and activity of DNA repair enzymes such as PARP1
[18–20]. PARP1 has been described to play an important
role in the metabolic regulation of cell death. PARP1 is
localized in the nucleus and can sense DNA damage, which
leads to the overactivation of PARP1 when DNA damage is
extensive[21,22].PARPoveractivationthencausesdepletion
of NAD and ATP and an acute bioenergetic depletion, which
promotes the release of apoptosis-inducing factor (AIF)
from the interspace of mitochondria and its translocation to
the nuclear compartment [23]. Within the nucleus, AIF is
supposed to be required for large-scale DNA fragmentation
in a caspase-independent manner [23]. This type of PARP1-
dependent necrotic cell death has been implicated in several
pathophysiological conditions, for example, upon cerebral
ischemia, oxygen-glucose depletion, or exposure to alkylat-
ing DNA-damaging agents [21, 22, 24].
The mitochondrial permeability transition pore complex
(PTPC) represents another multimeric protein complex that
has been implied in the bioenergetic control of several cell
death modalities [25]. The PTPC is composed of ANT,
an integral protein of the inner mitochondrial membrane
that is responsible for the exchange of ATP with ADP
across mitochondrial membranes [9], voltage-dependent
a n i o nc h a n n e l( V D A C ) ,ap r o t e i no ft h eo u t e rm i t o c h o n d r i a l
membrane [26], and cyclophilin D, which is localized to the
mitochondrial matrix [27]. The activity of VDAC is tightly
controlled by various mechanisms including proteins of the
B c l - 2f a m i l y ,i o n s ,a n dm e t a b o l i t e s .Th ek e yr o l eo fV D A Ci n
the regulation of necrotic cell death is underlined by genetic
evidence showing that mice deficient in cyclophilin D are
protected against ischemic injury [22, 28].
Downstream of the RIP1/RIP3 necrosome complex, met-
abolic pathways including glycogenolysis, and glutaminol-
ysis have also been implicated to mediate signaling events
during necroptosis. RIP3 has been shown to promote the
activity of several metabolic enzymes including glycogen
phosphorylase (PYGL), glutamate-ammonia ligase (GLUL),
and glutamate dehydrogenase 1 (GLUD1) [6]. PYGL is a key
enzyme in the catabolic metabolism of glycogen causing the
conversion of glycogen into glucose-1-phosphate which in
turn can be modified into glucose-6-phosphate, a substrate
for glycolysis that can promote the generation of ROS
via mitochondrial metabolic burst. In addition, RIP3 was
s h o w nt oa c t i v a t eG L U La n dG L U D 1[ 6], a cytosolic and
mitochondrial enzyme, respectively, involved in glutaminol-
ysis. Enhanced glutaminolysis can engage the Krebs cycle,
eventually contributing to increased ROS generation. Thus,
RIP3-dependent changes in glycogenolysis and glutaminoly-
sis can result in enhanced energy metabolism and increased
production of ROS.
6. Conclusions
Since its discovery, necroptosis has evolved as one of the
key programmed cell death pathways in mammalian cells,
whichisderegulatedinnumeroushumandiseases.Thanksto
enormous research efforts, considerable advances have been
achieved in the identification of the signal transduction steps
and control mechanisms that are involved in the control of
necroptosis signaling pathways. Metabolic events including
redox signaling represent critical events that are involved in
the regulation of necroptosis signaling. Further insights into
the fine-tuning of signaling processes will likely pave the
avenue towards novel opportunities to target specific inter-
vention points within in the necroptosis signaling cascade in
order to achieve therapeutic benefits.
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